Therapy News and Research

RSS

LCA: Few possess genetic mutation necessary for positive outcome from gene therapy

Leber congenital amaurosis (LCA) is a congenital retinal dystrophy present in approximately 1 of 80,000 births. It is estimated that about 3,000 people in the United States are living with LCA and will likely become blind in their lifetimes. Recently, there has been progress in gene therapy for this condition.

7 Apr 2010

Five helpings of fruits and vegetables a day may not cut cancer risk that much

Despite eating your five helpings of fruits and vegetables a day you may not be cutting your risk of cancer as suggested by a World Health organization study in 1997. The latest study based on healthy eating habits conducted by Mount Sinai School of Medicine in New York was published in the Journal of National Cancer Institute. The study was led by Paolo Boffetta and covered almost 500,000 Europeans.

7 Apr 2010

CancerGuide Diagnostics, Duke University form cancer research collaboration and licensing agreement

CancerGuide Diagnostics™, Inc. today announced that it has entered into a research collaboration and licensing agreement with Duke University to discover and develop tests to support individualized cancer treatment decisions.

7 Apr 2010

Newer treatments, closer monitoring of childhood cancer may improve longevity

Although more children today are surviving cancer than ever before, young patients successfully treated in the 1970s and 80s may live a decade less, on average, than the general population, according to a study from Dana-Farber Cancer Institute and the Harvard School of Public Health.

7 Apr 2010

Accumetrics completes enrollment phase of GRAVITAS clinical trial

Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy to use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced that it has completed the enrollment phase of its landmark clinical trial, GRAVITAS.

7 Apr 2010

Src can be most promising targets for cancer therapy

Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.

6 Apr 2010

Messenger substance plays significant role in viral diseases and reactions to infections

The connection with the blood circulatory system is a significant step in the development of cancer. Within the tissue where it is growing, the tumour develops an independent existence. With signal substances it entices white blood cells from the bone marrow into the tumour tissue.

6 Apr 2010

Oncologists to provide overview on new neuro-oncology guidelines

John Theurer Cancer Center at Hackensack University Medical Center will bring together top neuro-oncologists from around the country for an all day symposium to address new treatment updates and review management of complex cases across a broad array of neuro-oncology specialties.

6 Apr 2010

CAIRE plans to close liquid oxygen therapy manufacturing operations in Plainfield: Chart Industries

Chart Industries, Inc., a leading independent global manufacturer of highly engineered equipment used in the production, storage and end-use of hydrocarbon and industrial gases, today announced that CAIRE, which operates under Chart's BioMedical segment, plans to close its liquid oxygen therapy manufacturing operations in Plainfield, Indiana and relocate the manufacturing and customer service operations to a facility close to existing operations in Canton, Georgia where it manufactures the same product line.

6 Apr 2010

EPO upholds Nabi Biopharmaceuticals' opposition to Drug Abuse Therapy patent

Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.

6 Apr 2010

International experts recommend individualized treatment for type 2 diabetic patients

Patients with type 2 diabetes are generally treated similarly despite the fact that they may have underlying differences that could affect their therapeutic response.

6 Apr 2010

Comprehensive cardiac health study provides superior results

Kenneth "Buddy" Conant hit some clothing stores for a little shopping spree recently, but it wasn't because he'd suddenly become enthralled with the latest fashions. The truth was, he was starting to resemble a kid wearing a grown man's clothes.

6 Apr 2010

People with depression and anxiety disorders can benefit from exercise program

Exercise is a magic drug for many people with depression and anxiety disorders, and it should be more widely prescribed by mental health care providers, according to researchers who analyzed the results of numerous published studies.

6 Apr 2010

HHS grants $1.84 billion through Ryan White HIV/AIDS Program for HIV/AIDS care and medications

The U.S. Department of Health and Human Services today announced the release of more than $1.84 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.

6 Apr 2010

New muco-adhesive patch may help treat oral disorders

A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study.

6 Apr 2010

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

Alpha cells in the pancreas, which do not produce insulin, can convert into insulin-producing beta cells, advancing the prospect of regenerating beta cells as a cure for type 1 diabetes. The findings come from a study at the University of Geneva, co-funded by the Juvenile Diabetes Research Foundation, that is published today in the online edition of the scientific journal Nature.

6 Apr 2010

SCYNEXIS' SCY-635 inhibitor abstracts accepted for presentation at EASL Annual Meeting

Drug discovery company, SCYNEXIS, Inc. today announced that multiple abstracts related to the Company's cyclophilin inhibitor, SCY-635, were accepted for presentation at the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria, April 14-18, 2010.

6 Apr 2010

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

A scientist at Barrow Neurological Institute in Phoenix has been awarded a major grant from the Muscular Dystrophy Association to continue his groundbreaking work in the disease of myasthenia gravis.

6 Apr 2010

Dalfampridine drug for multiple sclerosis now available in the U.S.

A drug whose clinical benefit in treating multiple sclerosis was discovered at Rush University Medical Center was approved by the Food and Drug Administration on January 22 and is now available in the U.S.

6 Apr 2010

Ingen Technologies's SMART Nasal Cannula to be featured at upcoming Las Vegas MedTrade convention

Ingen Technologies, Inc., a leading manufacturer of respiratory medical devices, recently announced today that the SMART Nasal Cannula is a featured new product at the upcoming MedTrade convention in Las Vegas from May 10 through May 13, 2010. The Las Vegas MedTrade convention is the largest home health care expo in the world. Ingen is an exhibitor and will be part of the New Product showcase at MedTrade. The SMART Nasal Cannula is the Next-Generation of cannulas that improve oxygen therapy and reduce expenditures.

5 Apr 2010

Therapy News and Research

LCA: Few possess genetic mutation necessary for positive outcome from gene therapy

Five helpings of fruits and vegetables a day may not cut cancer risk that much

CancerGuide Diagnostics, Duke University form cancer research collaboration and licensing agreement

Newer treatments, closer monitoring of childhood cancer may improve longevity

Accumetrics completes enrollment phase of GRAVITAS clinical trial

Src can be most promising targets for cancer therapy

Messenger substance plays significant role in viral diseases and reactions to infections

Oncologists to provide overview on new neuro-oncology guidelines

CAIRE plans to close liquid oxygen therapy manufacturing operations in Plainfield: Chart Industries

EPO upholds Nabi Biopharmaceuticals' opposition to Drug Abuse Therapy patent

International experts recommend individualized treatment for type 2 diabetic patients

Comprehensive cardiac health study provides superior results

People with depression and anxiety disorders can benefit from exercise program

HHS grants $1.84 billion through Ryan White HIV/AIDS Program for HIV/AIDS care and medications

New muco-adhesive patch may help treat oral disorders

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

SCYNEXIS' SCY-635 inhibitor abstracts accepted for presentation at EASL Annual Meeting

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

Dalfampridine drug for multiple sclerosis now available in the U.S.

Ingen Technologies's SMART Nasal Cannula to be featured at upcoming Las Vegas MedTrade convention

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News